Data / Drug companies / Rifampin
Rifampin: 13 companies and 19 products in the FDA NDC directory
Rifampin is listed in the FDA National Drug Code Directory by 13 companies, with 19 products in commercial distribution. 19 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; injection, powder, lyophilized, for solution, and the newest product started marketing on July 20, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 19
- Generic (ANDA) products
- 19 (100.0%)
- Application numbers
- 7
- Routes
- Oral, Intravenous
- openFDA record search
- api.fda.gov
Companies that list rifampin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| American Health Packaging | 2 | capsule | Generic drugs (ANDA) | March 9, 2021 |
| Ani Pharmaceuticals, Inc. | 2 | capsule | Generic drugs (ANDA) | July 20, 2026 |
| Chartwell RX, LLC | 2 | capsule | Generic drugs (ANDA) | April 20, 2008 |
| Epic Pharma, LLC | 2 | capsule | Generic drugs (ANDA) | December 15, 2021 |
| Lupin Pharmaceuticals, Inc. | 2 | capsule | Generic drugs (ANDA) | January 8, 2014 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 2 | capsule | Generic drugs (ANDA) | March 14, 2023 |
| A-S Medication Solutions | 1 | capsule | Generic drugs (ANDA) | January 8, 2014 |
| Bryant Ranch Prepack | 1 | capsule | Generic drugs (ANDA) | January 8, 2014 |
| Coupler LLC | 1 | capsule | Generic drugs (ANDA) | October 13, 2025 |
| Fresenius Kabi USA, LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 21, 2014 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 3, 2016 |
| Major Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | February 25, 2025 |
| Mylan Institutional LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 21, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 16 | 84.2% |
| Injection, powder, lyophilized, for solution | 3 | 15.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 19 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Rifamycin Antibacterial | 19 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.